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Abstract of thesis 
The current scenario of rapidly increasing aging society, environmental stresses and increasing 
incidence of a variety of pathologies including cancer and brain functions are raising serious concerns in health 
management and sustaining QOL in normal and diseases states. While drug development requires huge amount 
of time, efforts and costs, a variety of plants and natural compounds have been used for anti-stress and disease 
preventive potentials in worldwide traditional home medicine systems. They have recently attracted attention 
in research laboratories to dissect their mode of action to promote safe and economic drug development. Cancer 
being highly complex, extremely difficult to treat and fatal, has attracted a lot of attention. In spite of the 
advances made in recent years, it faces worst prognosis and hence warrant continued research to develop new 
natural compounds with preventive and therapeutic potentials. Uncontrolled proliferation is one of the most 
consistent hall-mark of cancer cells. Cell culture provides excellent model system for study of cancer cells in 
normal, abnormal, stressed and drug-treated environments. It offers an easy detection of cancer promoting and 
inhibiting drugs. A variety of anticancer drugs have been identified by cell culture studies and are currently 
used in chemotherapy. The latter is toxic and complicated by undesirable secondary effects. Metastasis, cancer 
cell’s ability to move from the primary site and invade distant tissues in the body, accompanied by emergence 
of drug resistant variants, is another major hurdle in cancer treatment. Accordingly, newer economic and 
 patient friendly anti-metastasis molecules are deemed useful in intervention of cancer cell aggressiveness and 
drug resistant properties.  
The author has conducted research on the effect of Cucurbitacin B (a bioactive compound derived from 
Helicteres angustifolia, also known as Chinese Ginseng, roots) and Withanone (an active Withanolide derived 
from Withania somnifera, also known as Indian Ginseng, leaves) on cell proliferation of normal, cancer and 
stressed cells.  The author used human normal fibroblasts and a variety of cancer cells. By extensive titration 
of safe and cytotoxic doses, the author first found that whereas aqueous extract of Helicteres angustifolia roots 
(AQHAR) was selectively toxic to cancer cells, the purified active compound Cucurbitacin B was also 
cytotoxic to normal cells. On the other hand, Withanone, a bioactive isolated from Withania somnifera leaves, 
was selectively toxic to cancer cells. However, it showed poor efficacy. The author combined Cucurbitacin B 
(Cuc) and Witahnone (Wi-N) and developed a combination of Cucurbitacin B and Withanone (1:500 molar 
ratio; called CucWi-N) that showed selective toxicity to cancer cells; the normal cells remained unaffected. By 
a variety of molecular assays on human non-small-cell lung cancer cells, he found that CucWi-N possesses 
remarkable anticancer potential and was relatively safe for normal cells. The author undertook extensive 
analysis and demonstrated that CucWi-N induced cellular senescence in cancer cells. It was mediated by 
activation of p53 and inactivation of laminin signaling. Low doses of CucWi-N that were not cytotoxic to 
cancer cells were found to inhibit migration of cancer cells. The author investigated the mechanism of 
inhibition of cell migration by undertaking bioinformatics and experimental tools and found that Cucurbitacin 
B and Withanone strongly target hnRNP-K, a DNA and RNA binding protein essential for cell migration. It 
regulates cell migration and plays key role in cancer cell metastasis. In vivo tumor growth assays in nude mice 
using subcutaneous xenografts and tail vein metastasis models revealed tumor suppressor and anti-metastasis 
activity of CucWi-N. Furthermore, the author found that whereas the combination (CucWi-N) showed 
cytotoxicity and inhibition of migration in cancer cells, it protected normal cells against stresses. It was also 
seen to induce differentiation in glioblastoma cells.  Taken together, a novel combination of Cucurbitacin B 
and Withanone was generated that significantly and dose-dependently caused cytotoxicity to cancer cells and 
showed side-benefits to normal cells at low doses. Molecular analysis revealed selective cytotoxicity to cancer 
cells, their sensitization to environmental stressors, inhibition of cancer cell malignant properties including 
migration, stemness. Based on the data, the candidate proposed CucWi-N as a potential anticancer drug that 
warrants further mechanistic and clinical studies. 
Short-term viability assays of cultured cells in 96 well plates are routinely used to determine the 
cytotoxicity or safety of drugs. These are often based on formation of a chromogen, generated selectively in 
viable cells. The quantitative measures of the chromogen in a spectrophotometer at a specific wavelength are 
the conventional read-outs. The innate problems of such short term cell viability assays include (i) effect of 
drugs is determined by cell density and hence may show inconsistent results, (ii) some drugs have slow/gradual 
effect and hence may escape such assays, (iii) cell morphology that reveal significant hints to molecular 
signaling underlining the effect of drugs cannot be effectively captured, (iv) long-term effect on viability and 
clonogenic potential of cells that may be more relevant to chemotherapy cannot be determined and (v) herbal 
extracts and the purified active components often possess intrinsic color, which interferes with 
 spectrophotometer estimation and may yield inconsistent and even false results. In light of the ease and 
importance of cell culture-based assessment of drug safety and cytotoxicity, the author attempted to combine 
the conventional cell-based assays in a way that allows multiple readouts (quantitative and qualitative) from 
the single experiment, avoids the drawbacks of color interference. The author has established a Quantitative 
and Qualitative Cell Viability (QCV) assay in 12 well cell culture plates. The author provided experimental 
evidence that QCV could overcome cell density problem, interference of color of drugs and allowed long term 
observations on cell morphology and clonogenicity. The assay is easy to use and provides reliable read-outs.  
 
Abstract of assessment result 
【Review】 
The author developed a new combination of two natural compounds (Cucurbitacin B and Withanone) 
derived from Chinese ginseng and Indian ginseng, respectively. The author demonstrated that whereas 
Cucurbitacin B is toxic to normal cells, the combination of Cucurbitacin B and Withanone (1:500 molar ratio; 
called CucWi-N) was selectively toxic to cancer cells. The author investigated the molecular mechanism of 
anticancer properties of CucWi-N and found that it caused senescence in cancer cells that was mediated by 
activation of p53 and inactivation of Lamin signaling. Furthermore, inactivation of mortalin and hnRNP-K 
proteins contributed to decreased cell migration and metastasis of cancer cells. The author also developed a 
new protocol for accessing the cytotoxicity/viability of compounds possessing color. The author demonstrated 
that his protocol yields reliable results that are not affected by either cell density, growth characteristics of cells 
or even the innate color of test compounds. The study passes the criteria of originality, well planning and 
accomplishment. The objective of research is clear and well understood. Experimental models used are well 
suited. Interpretation of the results is clear and reasonable. Data analyses have been done using appropriate 
tools. The results and discussion sections are well written and interpreted. The study contributes significantly 
in the field of innovation and disease mechanisms with special reference to understanding of cancer and its 
interventions.  
 
【Result】 
The final examination committee conducted a meeting as a final examination on 4 July, 2018. The 
author provided an overview of dissertation, addressed questions and comments raised during Q&A session. 
All of the committee members reached a final decision that the applicant has passed the final examination. 
 
【Conclusion】 
Therefore, the final examination committee approved that the applicant is qualified to be awarded 
Doctor of Disease Mechanism. 
 
